Tag Archives: British Columbia

Movies & TV

Where Will Superman vs. Batman Film?

Leave a comment

Man of Steel was shot largely in Vancouver, but that’s not where its sequel — possibly titled Batman vs. Superman or Superman vs. Batman — will be filmed.

VanCityBuzz reports that the Warner Bros. sequel will lens in Toronto instead because their tax incentives for the film industry are better than those offered by British Columbia.

Henry Cavill is set to reprise his role as Superman. Also returning are director Zack Snyder, writer David S. Goyer, and cast members Amy Adams and Laurence Fishburne. The role of Batman has yet to be cast. The sequel is slated for a 2015 release.

Continue reading…

…read more

Source: FULL ARTICLE at IGN Movies

News, Politics, Government

'Glee' star died from heroin, alcohol mix: coroner

Leave a comment

Cory Monteith, the Canadian star of the hit TV musical series “Glee”, died of an apparent overdose of heroin and alcohol, the British Columbia coroner’s office said Tuesday.

The 31-year-old Monteith, who had struggled in the past with substance abuse and checked into a rehab facility in April, was found dead Saturday in his Vancouver hotel room

“There is no evidence to suggest this is anything other than the most sad and tragic accident,” coroner Barbara McLintock said in a statement released on YouTube.

“The cause of death was a mixed drug toxicity and it involved heroin, primarily, and also alcohol.”

McLintock said the coroner’s investigation was continuing, and that no further statements would be made until it was completed.

Monteith starred on “Glee” as Finn Hudson, a star high school football player who joined a motley crew of students in the glee club.

In the most recent season, he returned as a graduate coaching new singers.

Off-screen, Monteith dated his co-star Lea Michele, with whom he sang the show’s signature cover of Journey’s “Don’t Stop Believing.”

The actor had spoken openly about his past struggles with drugs and alcohol, which began in his youth.

Before shooting to nationwide fame on the Fox hit musical show, Monteith had played minor roles in TV series such as “Smallville” and “Kyle XY”.

…read more

Source: FULL ARTICLE at Fox World News

Articles of Interest

Heroin, Booze Killed Glee 's Cory Monteith

Leave a comment

By John Johnson

Cory Monteith’s autopsy is in, and his cause of death is what everybody expected: Hard drugs and booze. The coroner in British Columbia lays the blame on “mixed drug toxicity, involving heroin and alcohol,” reports TMZ . The 31-year-old Glee actor was found in his Vancouver hotel room over the weekend,… …read more

Source: FULL ARTICLE at Newser – Home

Science & Technology

Cloud Orb Caught Over Surrey, Canada On April 15, 2013.

Leave a comment

By ScottCWaring

Date of sighting: April 15, 2013
Location of sighting: Surrey, British Columbia, Canada

This UFO is a cloud orb. Notice how it exited the cloud but since there are very little clouds in the sky it has nowhere to hide. The deep blue of the sky makes it easy to see it and this is the perfect conditions to go UFO or orb hunting with your camcorder. SCW

Eyewitness states:
Captured this during my lunch break.Can someone tell me what it is? Please don’t say it is the ISS. ISS dosen’t fly that low(cloud Level)

From: http://www.ufosightingsdaily.com/2013/04/cloud-orb-caught-over-surrey-canada-on.html

Articles of Interest

Patients More Likely To Practice Preventive Behaviors If Doctors Do Them Too, Study Finds

Leave a comment

By The Huffington Post News Editors

A new study shows that doctors’ healthy behaviors may have an impact on their patients’ healthy behaviors.

The research, published in the Canadian Medical Association Journal, shows an association between doctors’ adherence to vaccine recommendations (like getting a flu shot) and patients’ adherence to the recommendations.

“While physicians’ health habits are generally exemplary, doctors could improve some of their personal screening and vaccination practices, which should improve the health practices of their patients,” study researcher Dr. Erica Frank, of the University of British Columbia, said in a statement.

Read More…
More on Video

From: http://www.huffingtonpost.com/2013/04/11/patients-preventive-behaviors-doctors-good-example_n_3038441.html

Business, Finance, Occupation & Industry

Orko and Coeur Announce Election Report

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Orko and Coeur Announce Election Report

VANCOUVER, British Columbia & COEUR D’ALENE, Idaho–(BUSINESS WIRE)– Orko Silver Corp. (“Orko”) (TSX-V: OK) (Frankfurt: OG3) (OTCUS: OKOFF) and Coeur d’Alene Mines Corporation (“Coeur”) (NYS: CDE) (TSX: CDM) are pleased to provide an update regarding the consideration to be received by Orko shareholders pursuant to the previously announced plan of arrangement (the “Arrangement”) whereby Coeur will acquire all of the issued and outstanding common shares of Orko (the “Orko Shares”). As previously announced, the Arrangement was approved by Orko shareholders yesterday.

Orko and Coeur received an election report from Computershare Trust Company of Canada setting out the number of common shares of Coeur (the “Coeur Shares“), warrants to purchase Coeur Shares (the “Coeur Warrants“) and/or cash consideration that each Orko shareholder will be entitled to receive pursuant to the Arrangement, after proration, as follows:

  • Orko shareholders who have elected or are deemed to have elected to receive the cash and share consideration will receive $0.70 cash, 0.0815 of a Coeur Share and 0.01118 of a Coeur Warrant for each Orko Share held;
  • Orko shareholders who have elected to receive the share consideration will receive 0.1118 of a Coeur Share and 0.01118 of a Coeur Warrant for each Orko Share held; and
  • Orko shareholders who have elected to receive the cash consideration will receive $0.74 cash, 0.0797 of a Coeur Share and 0.01118 of a Coeur Warrant for each Orko Share held.

The cash consideration alternative was oversubscribed, and pursuant to the proration methodology established under the Arrangement, Orko shareholders who have elected to receive the cash consideration will receive the cash, Coeur Shares and Coeur Warrants as described above.

Pursuant to the Arrangement, Orko shareholders will receive total cash consideration of CAD$100 million, 11,572,918 Coeur Shares and 1,588,768 Coeur Warrants. Following the completion of the Arrangement, the current Orko shareholders will hold approximately 11% of the issued and outstanding Coeur Shares (prior to the exercise of the Coeur Warrants). The Coeur Warrants will trade under the symbol “CDE.WS” on the NYSE and “CDM.WT” on the TSX. Trading is expected to commence on April 17, 2013 on both exchanges.

Orko will apply for a final order of the Supreme Court of British Columbia approving the Arrangement on Friday, April 12, 2013 and, assuming receipt of court approval and the satisfaction

From: http://www.dailyfinance.com/2013/04/11/orko-and-coeur-announce-election-report/

Business, Finance, Occupation & Industry

Postmedia Network Reports Second Quarter Results

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Postmedia Network Reports Second Quarter Results

TORONTO–(BUSINESS WIRE)– Postmedia Network Canada Corp. (“Postmedia” or the “Company”) today released financial information for the three and six months ended February 28, 2013.

Second Quarter Operating Results

Net loss in the quarter ended February 28, 2013 was $14.2 million compared to a net loss of $11.1 million in the same period in the prior year. The increase was primarily the result of foreign currency exchange losses partially offset by decreased losses on derivative financial instruments. Lower revenues in the quarter were offset by operating cost reductions.

Operating income of $5.8 million in the quarter increased $2.5 million compared to operating income of $3.3 million in the same period in the prior year.

Operating income before depreciation, amortization and restructuring of $25.2 million in the quarter represents a decrease of $0.1 million, relative to the same period in the prior year.

Revenue for the quarter was $178.8 million, a decrease of $19.8 million (10.0%) relative to the same period in the prior year. This decrease was primarily due to a decline in print advertising revenue of $16.9 million (13.8%) with the largest declines occurring in the classified and national advertising categories. Print circulation revenue decreased $3.3 million (6.5%) as a result of declines in circulation volumes partially offset by price increases. Digital revenue increased $0.4 million (1.7%) relative to the same period in the prior year.

Total operating expenses excluding depreciation, amortization and restructuring decreased $19.7 million (11.4%) relative to the same period in the prior year. Expense reductions occurred in all operating expense categories including compensation, newsprint, distribution and other operating expenses.

Year-to-Date Operating Results

Net loss in the six months ended February 28, 2013 was $5.9 million compared to net earnings of $17.3 million in the same period in the prior year. The decrease was due in part to the gain on sale of the Times Colonist in Victoria and British Columbia-based community newspaper assets to Glacier Media Inc. recorded in the same period of the previous year.

Net loss from continuing operations was $5.9 million, compared to net earnings of $3.2 million in the same period in the prior year.

Operating income was $32.5 million, a decrease of $5.0 million relative to the same period in

From: http://www.dailyfinance.com/2013/04/11/postmedia-network-reports-second-quarter-results/

Business, Finance, Occupation & Industry

Emergent BioSolutions Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Au

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Emergent BioSolutions Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Autoimmune Diseases

ROCKVILLE, Md.–(BUSINESS WIRE)– Emergent BioSolutions Inc. (NYS: EBS) announced today that it has presented data on ES210, one of its bispecific ADAPTIRTM (Modular Protein Technology) molecules, that is targeting autoimmune disease at Keystone Symposia’s Advances in the Knowledge and Treatment of Autoimmunity in Whistler, British Columbia, Canada.

The ES210 molecule was engineered using Emergent’s ADAPTIR technology platform and contains binding sites specific for CD86 coupled to a monomeric form of IL-10 known to confer immunosuppressive activity.

The poster, entitled “A Bispecific ADAPTIR™ Molecule That Targets CD86 and Delivers IL-10 Inhibits Antigen Presenting Cells and Has Potential as a Therapeutic Treatment of Autoimmune Disease,”presentedpre-clinical data showing that ES210 displays high levels of in vitro and in vivo potency in blocking T-cell proliferation in human mixed lymphocyte reactions and in a humanized graft-versus-host disease model. Dendritic cells play a central role in the generation and regulation of immunity; therefore, targeting dendritic cell function represents a therapeutic opportunity to suppress immunopathological processes in autoimmune disease.

“Emergent is investigating an ADAPTIR molecule that targets and blocks the co-stimulatory receptor CD86, while delivering the immunosuppressive cytokine IL-10 to CD86-expressing antigen presenting cells,” said Jane Gross, Ph.D., vice president of applied research at Emergent BioSolutions. “We are pleased to present the study results, which show the ADAPTIR molecule as having potential applications in the treatment of transplant rejection as well as autoimmune and inflammatory diseases such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.”

About the ADAPTIR™ Platform

ADAPTIR bispecific proteins are modular, single chain polypeptides that comprise two separate binding domains (VL and VH), a hinge segment, and an effector domain (huFc). They have a differentiated structure from monoclonal antibodies and can generate a unique signaling response. In addition, ADAPTIR proteins may mediate complement dependent cytotoxicity and Fc dependent cytotoxicity, similar to monoclonal antibodies.

ADAPTIR is the new trademark for Emergent BioSolutions Inc.’s modular protein technologies that were previously identified using the SCORPIONTM (multispecific protein therapeutic) and SMIPTM (monospecific protein therapeutic) trademarks. ADAPTIR and any and all Emergent BioSolutions Inc. brand, product, service and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All rights reserved.

About Emergent

From: http://www.dailyfinance.com/2013/04/11/emergent-biosolutions-presents-efficacy-data-on-es/

Business, Finance, Occupation & Industry

Orko Shareholders Approve Arrangement with Coeur

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Orko Shareholders Approve Arrangement with Coeur

VANCOUVER, British Columbia & COEUR D’ALENE, Idaho–(BUSINESS WIRE)– Orko Silver Corp. (“Orko”) (TSX-V: OK) (Frankfurt: OG3) (OTCUS: OKOFF) and Coeur d’Alene Mines Corporation (“Coeur”) (NYS: CDE) (TSX:CDM) are pleased to announce the positive results of the Orko shareholder vote to approve the previously announced plan of arrangement (the “Arrangement”) whereby Coeur will acquire all of the issued and outstanding common shares of Orko (the “Orko Shares“).

99.72% of the Orko Shares represented at Orko’s special shareholders’ meeting held earlier today were voted in favor of the special resolution approving the Arrangement.

Orko will apply for a final order of the Supreme Court of British Columbia approving the Arrangement on Friday, April 12, 2013 and, assuming receipt of court approval and the satisfaction or waiver of all remaining closing conditions, Orko and Coeur expect the Arrangement to be effective on or about April 16, 2013.

Gary Cope, Orko’s President and CEO, said, “We are extremely pleased to have received such overwhelmingly positive shareholder support for the Arrangement. The combination with Coeur will allow our shareholders to participate in a company with geographically diverse projects and robust growth prospects while retaining upside related to La Preciosa. We look forward to a smooth transition.”

Mitchell J. Krebs, Coeur’s President and CEO, said, “We look forward to leveraging Coeur’s financial and operational resources to realize the true value of Orko’s La Preciosa project. As a combined company, we will have enhanced asset and geographic portfolio diversification and robust growth prospects for our combined shareholder base.”

Orko shareholders with questions regarding the deposit of Orko Shares to the Arrangement can contact Kingsdale Shareholder Services Inc. toll free in North America at (888) 518-6812 or call collect outside North America at (416) 867-2272 or by email at contactus@kingsdaleshareholder.com.

About Orko

Orko Silver Corp. is developing one of the world’s largest undeveloped primary silver deposits, La Preciosa, located near the city of Durango, in the State of Durango, Mexico.

About Coeur

Coeur d’Alene Mines Corporation is the largest U.S.-based primary silver producer and a growing gold producer. The Company has four precious metals mines in the Americas generating strong production, sales and cash flow in continued robust metals

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

NovaGold Earnings: An Early Look

Leave a comment

By Dan Caplinger, The Motley Fool

Filed under:

Spring is finally here, and a new earnings season is right around the corner. On Wednesday, NovaGold Resources will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Gold mining stocks have gotten crushed over the past year, as a combination of weak bullion prices and cost-related struggles have led to intense pressure throughout the industry. Yet NovaGold has gotten the attention of hedge-fund investors John Paulson and Seth Klarman, who have taken sizable stakes in the company. Let’s take an early look at what’s been happening with NovaGold over the past quarter and what we’re likely to see in its quarterly report.

Stats on NovaGold Resources

Analyst EPS Estimate

($0.03)

Year-Ago EPS

$0.07

Revenue Estimate

$0

Year-Ago Revenue

$0

Earnings Beats in Past 4 Quarters

2

Source: S&P Capital IQ.

Will NovaGold Resources shine brighter this quarter?
It’s hard for analysts to get too excited about NovaGold because it hasn’t reported even minimal revenue since 2010. The single price target on the stock of $17.10 is wildly out of line with its current price, and shareholders have taken a substantial hit lately, with the stock having lost a quarter of its value since the beginning of the year.

NovaGold has several promising development-stage mining properties in its portfolio, although none of them has gotten to the production stage at this point. The company claims its Donlin Gold joint venture with Barrick Gold in Alaska is the world’s largest known undeveloped gold deposit, with project permitting having begun last August. Moreover, its Galore Creek venture with Teck Resources in British Columbia has promising prospects for copper, silver, and gold.

But the big problem that NovaGold has faced is that high production costs have made those projects less economically viable. Last summer, Barrick said that Donlin no longer met its goals for suitable investments because of substantial needs for capital, and although the permitting process has continued, it’s far from certain whether Barrick would be willing to go forward even if the project is approved. Meanwhile, NovaGold has said it would try to sell its 50% interest in Galore Creek, but the company has only been willing to enhance the project’s value on a reduced budget.

Meanwhile, NovaGold’s capital structure is becoming more precarious. Earlier this month, the company sent notice to its convertible bond holders that they could exercise their rights to sell the bonds back to NovaGold at par. NovaGold has enough cash to cover its repurchase of any bonds that investors offer, but with no revenue, it definitely …read more

Source: FULL ARTICLE at DailyFinance